Heart failure
Conditions
Interventions
None listed
Sponsors
Kobe University Graduate School of Medicine, Division of Cardiovascular Medicine, Depatment of Internal Medicine
Tokyo Institute of Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Heart failure patients who were diagnosed by Framingham criteria Controls without heart failure who have hypertension, diabetes, or dyslipidemia
Exclusion criteria
Exclusion criteria: Patients with collagen disease, malignancy, bowel disease, or kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gut microbiota | — |
Secondary
| Measure | Time frame |
|---|---|
| The metabolites of gut microbiota | — |
Countries
Japan
Contacts
Public ContactTomoya Yamashita
Kobe University Graduate School of Medicine Division of Cardiovascular Medicine, Department of Internal Medicine
Outcome results
None listed